710972-40-0 Usage
General Description
4-(2-Methoxyethylamino)piperidine-1-carboxylic Acid Tert-Butyl Ester is a chemical compound generally used in pharmaceuticals or for purposes of scientific research. This organic compound exhibits properties of both piperidine, an organic compound which is used as a building block in the synthesis of various pharmaceuticals, and tert-butyl ester, a compound used as a protection for carboxylic acids in organic synthesis. Its specific structure, composed of a piperidine ring with various functional groups attached, makes it useful in certain chemical reactions and synthesis processes. The presence of a methoxyethylamino group further contributes to its chemical reactivity and utility in pharmacological or chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 710972-40-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,1,0,9,7 and 2 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 710972-40:
(8*7)+(7*1)+(6*0)+(5*9)+(4*7)+(3*2)+(2*4)+(1*0)=150
150 % 10 = 0
So 710972-40-0 is a valid CAS Registry Number.
InChI:InChI=1/C13H26N2O3/c1-13(2,3)18-12(16)15-8-5-11(6-9-15)14-7-10-17-4/h11,14H,5-10H2,1-4H3
710972-40-0Relevant articles and documents
INHIBITORS OF INDOLEAMINE 2,3-DIOXYGENASE AND METHODS OF THEIR USE
-
Page/Page column 140-141, (2020/02/16)
The present invention provides compounds of formula (I): wherein all of the variables are as defined herein. These compounds are inhibitors of indoleamine 2,3-dioxygenase (IDO), which may be used as medicaments for the treatment of proliferative disorders, such as cancer, viral infections and/or autoimmune diseases.
MUSCARINIC AGONISTS
-
Page/Page column 59, (2017/02/28)
This invention relates to compounds that are agonists of the muscarinic receptor and/or M4 receptor and which are useful in the treatment of muscarinic M1/M4 receptor mediated diseases. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds. Compounds include those according to formula (1a) or a salt thereof, wherein p, q, r, s, Q, R3 and R4 are as defined herein.
PYRIMIDINE DERIVATIVES AS PI3K INHIBITORS
-
Page/Page column 94-95; 101-102, (2008/06/13)
Thienopyrimidines of formula (Ia) or (Ib): wherein R1, R2, R3, are as defined in the claims.
